TIDMAMS

RNS Number : 3114I

Advanced Medical Solutions Grp PLC

16 June 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                             Advanced Medical Solutions 
  the underlying issuer                                            Group plc 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
------------------------------------------------------  ------------------------------ 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                         ü 
-------------------------------------------------------  ----------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-------------------------------------------------------  ----------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
-------------------------------------------------------  ----------------------------- 
 An event changing the breakdown of voting rights 
-------------------------------------------------------  ----------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------    ----------------------------- 
 3. Full name of person(s)                               Octopus Investments Nominees 
  subject to the                                                    Limited 
  notification obligation: 
  (iii) 
------------------------------------------------------  ------------------------------ 
 4. Full name of shareholder(s)                                       n/a 
  (if different from 3.):(iv) 
------------------------------------------------------  ------------------------------ 
 5. Date of the transaction                                       14/06/2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
------------------------------------------------------  ------------------------------ 
 6. Date on which issuer                                          15/06/2017 
  notified: 
------------------------------------------------------  ------------------------------ 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                                  9% 
------------------------------------------------------  ------------------------------ 
 
 
 
 8. Notified details: n/a 
----------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
----------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous              Resulting situation after the 
  of              to the triggering               triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ------------------------------  ----------------------------------------------------------- 
                 Number          Number          Number         Number of                % of voting 
                  of              of              of shares      voting                   rights (x) 
                  Shares          Voting                         rights 
                                  Rights 
--------------  --------------  --------------  -------------  -----------------------  ------------------- 
                                                 Direct         Direct       Indirect    Direct    Indirect 
                                                                 (xi)         (xii) 
--------------    ------------   ------------   -------------  -----------  ----------  --------  --------- 
 GB0004536594    19035840        19035840        19021930       19021930                 8.99% 
                --------------  --------------  -------------  -----------  ----------  --------  --------- 
 
 
 B: Qualifying Financial Instruments 
----------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------------------- 
 Type of           Expiration     Exercise/                      Number of voting        % of voting 
  financial         date           Conversion                     rights that             rights 
  instrument        (xiii)         Period (xiv)                   may be 
                                                                  acquired if 
                                                                  the 
                                                                  instrument 
                                                                  is 
                                                                  exercised/ 
                                                                  converted. 
----------------  -------------  -----------------------------  ----------------------  ------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------------------- 
 Type of          Exercise       Expiration     Exercise/       Number of voting         % of voting 
  financial        price         date           Conversion       rights instrument        rights (xix, 
  instrument                     (xvii)         period           refers to                xx) 
                                                (xviii) 
---------------  -------------  -------------  --------------  -----------------------  ------------------- 
                                                                                         Nominal   Delta 
---------------  -------------  -------------  --------------  -----------------------  --------  --------- 
 
 
 Total (A+B+C) 
----------------------------------------------------------------------------------------------------------- 
 Number of voting rights                          Percentage of voting rights 
-----------------------------------------------  ---------------------------------------------------------- 
 19021930                                         8.99% 
-----------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
-------------------------------------------------------------------------- 
 
   n/a 
 
 Proxy Voting: 
-------------------------------------------------------------------------- 
 10. Name of the proxy holder:                            n/a 
-------------------------------------------------------  ----------------- 
 11. Number of voting rights proxy                        n/a 
  holder will cease to hold: 
-------------------------------------------------------  ----------------- 
 12. Date on which proxy holder will                      n/a 
  cease to hold voting rights: 
-------------------------------------------------------  ----------------- 
 
 
  13. Additional information: 
-------------------------------------------------------  ----------------- 
 14. Contact name:                                        Annaliese Maisch 
-------------------------------------------------------  ----------------- 
 15. Contact telephone number:                            020 7716 6477 
-------------------------------------------------------  ----------------- 
 
 
 
 Note: Annex should only be submitted to the FCA not 
  the issuer 
 Annex: Notification of major interests in share 
 
 A: Identity of the persons or legal entity subject to 
  the notification obligation 
---------------------------------------------------------------- 
 Full name                              Peter Orsi 
  (including legal form of 
  legal entities) 
-------------------------------------  ------------------------- 
 Contact address                        33 Holborn, London, EC1N 
  (registered office for legal           2HT 
  entities) 
-------------------------------------  ------------------------- 
 Phone number & email                   020 7710 2877 
-------------------------------------  ------------------------- 
 Other useful information 
  (at least legal representative 
  for legal persons) 
-------------------------------------  ------------------------- 
 
 B: Identity of the notifier, if applicable 
---------------------------------------------------------------- 
 Full name 
-------------------------------------  ------------------------- 
 Contact address 
-------------------------------------  ------------------------- 
 Phone number & email 
-------------------------------------  ------------------------- 
 Other useful information 
  (e.g. functional relationship 
  with the person or legal 
  entity subject to the notification 
  obligation) 
-------------------------------------  ------------------------- 
 
 C: Additional information 
---------------------------------------------------------------- 
 
 For notes on how to complete form TR-1 please see the 
  FCA website. 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUNSBRBOANARR

(END) Dow Jones Newswires

June 16, 2017 03:47 ET (07:47 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.